EP2114874A2 - Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof - Google Patents

Abstract

The invention relates to a method for preparing polyfluorinated sulphanylamides of formula (I) and polyfluorinated sulphinamidines of formula (II), wherein R1-R4 are defined as in the claims, and for preparing the precursors of same.

Description

 PROCESS FOR THE PREPARATION OF FLUORINATED SULFANYLAMIDES AND SULFINAMIDINES AND USES THEREOF

The present invention relates to a process for the preparation of fluorinated sulfanylamides and sulfinamidines.

The present invention relates to a process for the preparation of novel polyfluorinated sulfanylamides and sulfinamidines and their precursors and the potential use of these sulfanylamides as possible substitutes for hydrophobic groups or carboxylic acids contained in certain bioactive molecules or as a perfluoroalkylsulfanylation agent.

Fluorine chemistry has undergone a spectacular development in recent decades due to the importance of fluorinated molecules in fields as diverse as polymers, battery salts, surfactants, dyes, liquid crystals , coolants, agrochemistry and pharmacy [(a) Topics in Applied Chemistry. Organofluorine Chemistry, Principles and Commercial Applications. R. E. Banks, B.E. Smart and J. C. Tatlow. Plenum Press, New York, 1994 (b) Chem. Organic. Chem., 2004, No. 5, Special Issue "Fluorin in Life Sciences" (c) Chemistry of Organic Fluorine Compounds. Compounds II. A Critical Review. Mr. Hudlicky and A. E. Pavlath. ACS Washington, 1995 (d) Organofluorine Compounds. Chemistry and Applications. T. Hiyama. Springer, 2000].

In the field of pharmacy, the figures show that the number of molecules comprising at least one fluorine atom and in pre-clinical or clinical development has been multiplied by 2.5 in twenty years [Inventory of Industrial Fluoro-Biochemicals. A. Becker. Eyrolles, Paris, 1996]. The corresponding therapeutic indications range from the central nervous system to anti-cancer, including antibiotics, anti-diabetics, anti-inflammatories and antihypertensives [Bioorganic and Medicinal Fluorine Chemistry, JP Bégué, D. Bonnet-Delpon, CNRS Editions , 2005]. Because of its marked lipophilicity, small size and polarized nature of the CF bond [(a) Fluorine-Containing Molecules. Structure, Reactivity, Synthesis and Applications. JF Liebman, A. Greenberg, WR Dolbier. VCH, Weinheim, 1988 (b) Organofluorine Chemistry. K. Uneyama. Blackwell Publishing, Oxford, 2006 (c) Scholfield, HJ Fluorine Chem. 1999, 100, 7-11], the introduction of one or more fluorine atoms into a biologically active molecule often results in better pharmacokinetic properties (thanks to increased resistance to metabolism and facilitated gastrointestinal absorption), as well as improved enzymatic or cellular activities (thanks to permeation facilitated through membranes, sometimes enhanced with the target or irreversible inhibition thereof) [Biomedical Frontiers of Fluorine Chemistry. I. Ojima, JR McCarthy, JT. Welch. ACS, Washington, 1996]. The polyfluoro groups most used in agrochemicals and pharmaceuticals are the groups CF ₃ , OCF ₃ , SCF ₃ , SO ₂ CF ₃ , OCHF ₂ and SCHF _{2, all of} which are characterized by a marked hydrophobic character.

The methods of introducing fluorine or polyfluorinated groups are numerous and apply both in the aliphatic and aromatic series [(a) Organofluorine Compounds. Chemistry and Applications. T. Hiyama. Springer, 2000 (b) Organofluorine Chemistry. K. Uneyama. Blackwell Publishing, Oxford, 2006 (c) Houben-Weyl Methods of Organic Chemistry. ^4th Edition. Organo-Fluorine Compounds. Volume E10. B. Baasner, H. Hagemann, JC Tatlow. George Thieme, Verlag, Stuttgart, 1999 (d) Langlois, BR; Ratton, S .; Paris, JM L'actualité Chimique 2006, No. 301-302, 56-66] Among the most widely used reactions, the conversion of alcohols and carbonyl functions to the corresponding fluorinated and difluorinated derivatives by diethylaminosulfur trifluoride ( DAST) [(a) Middleton, WJJ Org Chem 1975, 40, 574-578 (b) Hudlicky, M. Org React 1988, 35, 513-637], Halex reactions that convert a halogeno- or nitro arenes in fluoroarenes [(a) Clark et al., Rev. 1999, 28, 225-231 (b) The Roots of Organic Development, P244-292, BR Langlois, L. Gilbert, G. Forat . Elsevier, Amsterdam, 1996], the electrophilic fluorination of ketones by Λ / or fluoro sulfonylimides Selectfluor ^® [(a) Banks YEN Fluorine Chem. 1998, 87, 1-17 (b) Cahard et al. Chem. Rev. 2004, 104, 6119-6146] or else the trifluoromethylation reactions, those of the carbonyl compounds by nucleophilic means, with the Ruppert reagent (CF ₃ TMS) [(a) Prakash et al., Chem Rev. 1 997, 97, 757-786 (b) Langlois et al. Synthesis 2003, 185-194], and electrophilically with Umemoto's reagent [Umemoto, T. Chem. Rev. 1996, 96, 1757-1778], or those of the halo-aromatics [Burton et al. J. Am. Chem. Soc. 1986, 708, 832-834].

These fluorination methods often have limitations so that the introduction of a fluorine or a polyfluorinated group on a given molecule at a given position still remains, in many cases, a delicate problem for the chemist . Given the importance of fluorinated molecules, any improvements in known fluorination methods or any new discoveries of fluoridation methodologies or reagents would be of great benefit in many areas. In particular, the discovery of new methods of direct introduction of a SCF ₃ group

(aromatic trifluoromethylsulfanylation series, aliphatic or on a hetero atom) using non-toxic reagents under mild conditions, would allow to overcome the limitations of the methods described today and thus to access more easily molecules of interest for their potential applications in agrochemistry and pharmacy, areas where the molecules containing a group SCF ₃ are common [(a) Inventory of Industrial Fluoro-Biochemicals. A. Becker. Eyrolles, Paris, 1996 (b) Fluorine Compounds as Agrochemicals. ^2nd Edition. SB Walker. BARK Information Services, Wokingham, UK, 1995]. The known methods of direct trifluoromethylsulfanylation rely on mechanisms of electrophilic nature (via a species SCF ₃ ⁺ ), nucleophilic (via a species SCF ₃ ^" ) or radical (via a species SCF ₃ ) and use reagents like CF ₃ SCI Haas et al .: (a) Chem Ber, 1976, 109, 2475-2484 (b) Chem Chem Acta 1979, 62, 1442-1450 (c) J. Fluorine Chem 1984, 24, 363-368 ], CF ₃ SSCF ₃ [Peach, ME Can J. Chem., 1967, 45, 429-432], CF ₃ SH [Harris et al J. Am.Chem.Soc. 1961, 83, 840-845], Hg (SCF ₃ ) ₂ [Brandt et al J. Chem Soc 1952, 2198-2205], AgSCF ₃ [Emelus et al J. Chem Soc 1961, 2597-2599], CuSCF ₃ [Yagulpolskii et al. Synthesis 1975, 721-723] or MSCF ₃ (with M ⁺ = Cs ⁺ or Me ₄ N ⁺ ) [Tyraa et al J. Fluorine Chem 2003, 119, 101-107] which are generally very toxic (or are prepared from highly toxic compounds) and give rise to reactions that are not transferable on an industrial scale (gauze state ux, excessive cost and difficult handling due to toxicity).

Among the molecules bearing a SCF ₃ group, trifluoromethylsulfanylamides which are characterized by an N-SCF _{3 group} are poorly documented because they are mainly obtained by reacting an amine (primary or secondary) or an amide with CF ₃ SCI (toxic gas ) [(a) Haas et al. J. Heterocycl. Chem. 1986, 23, 1079-1084 (b) Shreeve et al. Inorg. Chem. 1985, 24, 2126-2129 (c) Munavalli et al. Phosphorus, Sulfur Silicon Relat. Elem. 2003, 778, 107-113], or CF ₃ SSCF ₃ whose toxicity comparable to that of phosgene [Peach, ME Can. J. Chem. 1967, 45, 429-432]. Other methods use CF ₃ SNH ₂ [Haas et al. Chem. Ber. 1982, 115, 523-532] or CF ₃ SNCO [(a) Haas et al. Chem. Ber. 1982, 775, 533-539 (b) Haas, A. Chem. Ber. 1966, 99, 3103-3107], also toxic reagents, for the preparation of cyclic sulfanylamides or derivatives of carbamates and ureas. Although not easily accessible, trifluoromethylsulfanylamides may have various biological properties as illustrated by the molecules below [Bayer AG Patents (WO2002006277, 2002; DE2045441, 1972; DE2103199, 1972); Boehringer-Mannheim patent (DE2727550, 1979); Merck Patents (GB2266527, 1993; EP481671, 1992; EP199630, 1986)].

Moreover, trifluoromethylsulfinamidines constitute another class of molecules carrying a SCF ₃ group, the latter being integrated into a sequence of the N = S (CF ₃ ) -N type. These compounds are hardly and exclusively prepared from

CF ₃ SF ₃ [(a) Glemser et al. Z. Naturforsch., B 1978, 33, 1417-1421 (b) Mews et al.

Chem. Ber. 1991, 124, 2411-2416 (c) Yagupolskii et al. Zh. Org. Khim. 1980, 16, 863-

867]. This reagent is itself prepared from SF ₄ , a difficult-to-handle compound, which explains the limited number of known trifluoromethylsulfinamidines.

The present invention relates to a process for the preparation of the sulfanylamide compound of formula (I) and of the sulfinamidine compound formula (II)

in which a) R ₁ represents:

or an optionally substituted aryl group;

or an optionally substituted heteroaryl group; an optionally substituted alkyl group; or an optionally substituted cycloalkyl group;

or an optionally substituted heterocycloalkyl group;

or an -SO ₂ -aryl group in which the aryl is optionally substituted;

or a -SO ₂ -heteroaryl group in which the heteroaryl is optionally substituted; or a -SO ₂ -fluoroalkyl group;

or a -CO ₂ -aryl group in which the aryl is optionally substituted;

or a -CO ₂ -heteroaryl group in which the heteroaryl is optionally substituted;

or a -CO ₂ -alkyl group in which the alkyl is optionally substituted; b) R ₂ represents a perfluorofluoroalkyl or difluoromethylene group substituted with a -S-aryl, -S-heteroaryl or benzoxazol-2-yl group. The aryl, heteroaryl and benzoxazole groups are optionally substituted,

c) R ₃ and R ₄ represent, independently of one another, an alkyl, alkoxyalkyl or cycloalkyl group, or else R ₃ and R ₄ together with the nitrogen atom to which they are attached form a saturated or unsaturated heterocycle; 3- to 7-membered ring optionally comprising another heteroatom (such as piperidinyl, pirrolidinyl or morpholinyl);

characterized in that the following steps are carried out:

- a ^1st step, wherein the compound of formula (IV) is condensed with a compound of formula (V) in the presence of a tertiary amine (such as triethylamine, Λ /, Λ / diisopropylethylamine, pyridine, 2,6 -lutidine) in an organic solvent, preferably in a non-polar solvent such as dichloromethane, to give the compound of formula (III), in which R ₁ , R ₂ , R ₃ and R ₄ are as defined above and R ₅ , R ₆ and R ₇ independently of one another represent a group selected from optionally substituted alkyl or aryl groups;

- a ^2nd stage, wherein the compound of formula (III) is itself fused to a compound of formula Rinh _2, wherein R ₁ is as defined above, in the presence of a tertiary amine (such as triethylamine, Λ /, Λ / -diisopropylethylamine, pyridine, 2,6-lutidine) in an organic solvent, to give a sulfanylamide of formula (I) or a sulfinamidine compound of formula (II), wherein R ₁ , R ₂ , R ₃ and R ₄ are as previously defined;

- optionally a 3 ^rd step, wherein the sulfinamidine compound of formula (II) is converted in an organic solvent in the presence of an acid to give a sulfanylamide compound of formula (I), wherein R ₁ and R _2, R ₃ and R ₄ are as previously defined.

The term "optionally substituted aryl" means an aryl group optionally substituted with one or more groups (for example from 1 to 3) groups, identical to or different from one another, chosen from the following atoms and groups:

• halogen,

• optionally substituted alkyl,

• alkoxy, • optionally substituted aryl,

Optionally substituted heteroaryl,

• alkylene,

• alkynyl,

Fluoroalkyl, fluoroalkoxy,

Optionally substituted O-aryl,

Optionally substituted O-heteroaryl,

• -S-alkyl,

• -S-fluoroalkyl, -S-aryl optionally substituted,

Optionally substituted S-heteroaryl,

• -CN,. -NO ₂ ,

Heterocycloalkyl, -N (R ₃ ) (R _b ),

• -N (R ₃ ) CO (R _b ), -N (R ₃ ) COO (R _C ),

• -N (R _c ) CON (R _a ) (R _b ),

• -N (R _a ) SO ₂ (R ₀ ),

-OSO ₂ Rc, -SO ₂ N (R ₃ ) (R _b ),

• -SO ₂ (Rc),

• -CON (R _a ) (R _b ),

• -CORb and

• -COOR _0, wherein R _a and R _b are independently selected from hydrogen, a (C ₁ - C ₄₎ optionally substituted alkyl, (C ₁ -C ₄₎ fluoroalkyl, cycloalkyl, optionally substituted aryl, heteroaryl optionally substituted, heterocycloalkyl and R _c takes the values of R _a except hydrogen, or R _a and R _b together with the nitrogen atom to which they are attached form a saturated or unsaturated 3 to 7-membered heterocycle, comprising possibly another heteroatom.

The term "heteroaryl", optionally substituted, is understood to mean a heteroaryl group optionally substituted with one or more groups (for example 1 to 3) groups, identical to or different from each other, chosen from the following atoms and groups:

• halogen,

• optionally substituted alkyl,

• alkoxy,

Optionally substituted aryl, optionally substituted heteroaryl,

• alkylene,

• alkynyl,

• fluoroalkyl,

Optionally substituted fluoroalkoxy, -O-aryl,

Optionally substituted O-heteroaryl,

• -S-alkyl,

• -S-fluoroalkyl,

Optionally substituted -S-aryl; -S-heteroaryl optionally substituted, • -CN,

• -NO ₂ ,

Heterocycloalkyl,

• -N (Ra) (Rb) ₁ • -N (R ₈ ) CO (Rb),

-N (R _a ) COO (R ₀ ),

. -N (R _c ) CON (R _a ) (R _b ),

• -N (R ₃ ) SO ₂ (Rc),

-OSO ₂ R _c , -SO ₂ N (R ₃ ) (Rb),

• -SO ₂ (Rc),

. -CON (R ₃ ) (Rb),

• -C0R _b and

-COOR _c , wherein R ₃ , R _b and R _c are as defined above;

The term "optionally substituted alkyl" denotes an alkyl group optionally substituted with one or more groups (for example 1 to 3) groups, identical to or different from one another, chosen from the following atoms and groups: • halogen,

• optionally substituted aryl,

Optionally substituted heteroaryl,

Heterocycloalkyl,

Alkoxy, fluoroalkyl,

• fluoroalkoxy,

Optionally substituted O-aryl,

Optionally substituted O-heteroaryl,

• -S-alkyl, -S-fluoroalkyl,

Optionally substituted -S-aryl,

Optionally substituted S-heteroaryl,

• -CN,

• -NO ₂ , • -SO ₂ N (R ₃ ) (R _b ), • -SO ₂ (Rc),

• -COR _b ,

• -COOR _c ,

-CON (R ₈ ) (Rb) ₁ • -N (R ₈ ) (Rb),

. -N (R ₈ ) CO (Rb),

• -N (R ₃ ) COO (RC),

. -N (R _c ) CON (R _a ) (R _b ), and. -N (R ₃ ) SO ₂ (Rc), wherein R _a , Rb and R _c are as previously defined;

In the context of the present invention, and unless otherwise stated in the text, the following terms mean:

a halogen atom: a fluorine, a chlorine, a bromine or an iodine. an alkyl group: a saturated aliphatic group comprising from 1 to 12 carbon atoms (advantageously from 1 to 6 carbon atoms) and being linear or branched. By way of examples, mention may be made of methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, pentyl, hexyl and the like.

an alkoxy group: an -O-alkyl radical in which the alkyl group is as defined above.

an alkoxyalkyl group: a radical of formula alkyl-O-alkyl, in which the alkyl groups, which are identical to or different from one another, are as defined previously.

a fluoroalkyl group: an alkyl group as defined above and comprising between 1 and 13 fluorine atoms, preferentially from 1 to 5. By way of examples, mention may be made of the -CH ₂ F, -CHF _{2 groups} , -CF ₃ , -CH ₂ CF ₃ and -CF ₂ CF ₃ . The group is said perfluoroalkyl when each hydrogen atom of the alkyl group is replaced by a fluorine atom as in -CF ₂ CF ₃ .

a fluoroalkoxy group: an alkoxy group as defined above and comprising between 1 and 9 fluorine atoms. By way of examples, mention may be made of the groups -O-CH ₂ F, -O-CHF ₂ , -O-CF ₃ , -O-CH ₂ CF ₃ and -OCF ₂ CF ₃ , -OCH (CF ₃ ) ₂ . The group is perfluoroalkoxy when each hydrogen atom of the alkyl group is replaced by a fluorine atom as in -OCF ₂ CF ₃ .

an alkylene group: a linear or branched hydrocarbon group having one or more unsaturations and having 2 to 12 carbon atoms, preferably between 2 and 6 carbon atoms. The substituents ethylenyl, 1-methylethylenyl, prop-1-enyl, prop-2-enyl, Z-1-methylprop-1-enyl, E-1-methylprop-1-enyl, Z-1,2-dimethylpropion 1- enyl, E-1, 2-dimethylprop-1-enyl, but-1,3-dienyl, 1-methylidenyl-prop-2-enyl, 2-methylbut-1,3-dienyl, E-2-methylbutyl 1,3-dienyl, 2-methyl-1-methylidenylprop-2-enyl, undec-1-enyl and undec-10-enyl are examples of alkylene substituents.

an alkynyl group: a linear or branched hydrocarbon substituent having at least two unsaturations borne by a pair of vicinal carbon atoms having from 2 to 12 carbon atoms, preferably from 2 to 6 carbon atoms. The substituents ethynyl, prop-1-ynyl, prop-2-ynyl, and but-1-ynyl are examples of alkynyl substituents.

a cycloalkyl group: a saturated or partially unsaturated mono or polycyclic hydrocarbon group having from 3 to 12 carbon atoms, preferably between 3 and 12 carbon atoms;

6 carbon atoms. The cyclopropyl, cyclobutyl, cyclopentyl, cyclopentenyl, cyclopentadienyl, cyclohexyl, cyclohexenyl, cycloheptyl, bicyclo [2.2.1] heptyl, cyclooctyl, bicyclo [2.2.2] octyl, adamantyl and perhydronaphthyl substituents are examples of cycloalkyl substituents. a heterocycloalkyl group: a cyclic carbon group comprising between 4 and 8 members and between 1 and 4 heteroatoms chosen from nitrogen, oxygen and sulfur. This heterocycloalkyl group may be substituted, at any position, including on ring nitrogen atoms, with one or more groups, which are identical or different from one another, chosen from fluorine and optionally substituted alkyl or alkoxy groups. alkoxyalkyl, oxo, -CF ₃ , -OCF ₃ , -COOalkyl, -CO-NRR ', NRCOR ¹ and -NRR ¹ , wherein R and R' represent a hydrogen atom or a - (CrC ₄ ) alkyl group. By way of example, there may be mentioned morpholine, pyrrolidine, piperidine, piperazine, 2-pyrrolidinone, 2-piperidinone, imidazoline, and imidazolidine-2,4-dione groups.

an aryl group: a mono- or polycyclic aromatic substituent having from 6 to 14 carbon atoms. The substituents phenyl, naphth-1-yl, naphth-2-yl, anthracen-9-yl, 1, 2,3,4-tetrahydronaphth-5-yl and 1,2,3,4-tetrahydronaphth-6-yl are examples of aryl substituents.

a heteroaryl group: a mono- or polycyclic heteroaromatic substituent having from 1 to 13 carbon atoms and from 1 to 4 heteroatoms. The substituents pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, furyl, thienyl, imidazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, 1,2,4-triazolyl, oxadiazolyl, thiadiazolyl, tetrazolyl, pyridyl, pyrimidyl, pyrazinyl, 1,3,5-triazinyl, indolyl, benzo [b] furyl, benzo [b] thienyl, indazolyl, benzimidazolyl, azaindolyl, quinolyl, isoquinolyl, carbazolyl and acridyl are examples of heteroaryl substituents. - a "heteroatom": an atom at least divalent, different from carbon. N, O and

S are examples of heteroatoms. There may be mentioned a preparation method according to the present invention as defined previously for which R ₁ represents:

or an aryl optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from the following atoms and groups:

• halogen,

• optionally substituted alkyl,

• alkoxy, • optionally substituted aryl,

Optionally substituted heteroaryl,

• alkylene,

• alkynyl,

Fluoroalkyl, fluoroalkoxy,

• -S-fluoroalkyl,

• -CN,

• -NO ₂ ,

Heterocycloalkyl, -N (R ₃ ) (R _b ),

• -N (R ₃ ) CO (R _b ),

• -N (R ₃ ) COO (R _c ),

• -OSO ₂ Rc,

• -CON (R ₃ ) (R _b ), -COR _b and

• -COOR _c, wherein R ₃ and R _b are independently selected from a hydrogen atom, a (dC ₄₎ alkyl, optionally substituted (C ₁ -C ₄₎ fluorooalkyle, cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, heterocycloalkyl and R _c takes the values of R ₃ except hydrogen, or R ₃ and R _b together with the nitrogen atom to which they are attached form a saturated or unsaturated 3 to 7-membered heterocycle optionally comprising another heteroatom ; or a heteroaryl optionally substituted with one or more (for example 1 to 3) groups, identical or different from each other, chosen from the following atoms and groups: • halogen,

• optionally substituted alkyl,

• alkoxy,

Fluoroalkyl, fluoroalkoxy,

• -CN,

• -N (Ra) (Rb),

• -COR _b and

• -COORc, where R _a , R _b and R _c are as defined previously;

or an alkyl optionally substituted with one or more groups (for example 1 to 3) groups, identical or different from one another, chosen from the following atoms and groups:

Halogen, optionally substituted aryl,

Optionally substituted heteroaryl,

Heterocycloalkyl,

• alkoxy,

• -S-alkyl, • fluoroalkyl,

• fluoroalkoxy,

• -CN,

• -NO ₂

-COOR _c , -CON (R ₃ ) (R _b ),

• -N (R ₃ ) (Rb),

. -N (Ra) CO (Rb),

-N (R _a ) COO (R ₀ ),

. -N (R _c ) CON (Ra) (R _b ), and • -N (R ₃ ) SO ₂ (Rc), wherein R _a , R _b and R _c are as previously defined;

or an -SO ₂ -aryl group in which the aryl is optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from the following atoms and groups: • halogen, • alkyl,

• alkoxy,

• fluoroalkyl,

• fluoroalkoxy, • -CN,

. -NO ₂ ,

. -N (Ra) (Rb),

• -COR _b and

• -COORc, where R ₃ , R _b and R _c are as defined previously; or a -SO ₂ -heteroaryl group where the heteroaryl is optionally substituted with one or more (for example 1 to 3) groups, identical or different from each other, chosen from the following atoms and groups: • halogen,

• alkyl,

• alkoxy,

• fluoroalkyl,

• fluoroalkoxy, • -CN,

. -N (R ₃ ) (R _b ),

• -COR _b and

• -COORc, where R _a , R _b and R _c are as defined previously; or a -SO ₂ -fluoroalkyl group;

or a -CO ₂ -alkyl group in which the alkyl is optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from the following atoms and groups:

• fluorine, • optionally substituted aryl,

Optionally substituted heteroaryl,

Heterocycloalkyl,

• alkoxy,

• -S-alkyl, • fluoroalkyl, • fluoroalkoxy,

• -CN ₁

• -NO ₂

• -COOR _c ,. -CON (Ra) (Rb) ₁

• -N (Ra) (Rb),

. -N (R _a ) CO (R _b ),

• -N (R _a ) COO (R _c ),

. -N (R _c ) CON (R _a ) (R _b ), and • -N (R ₃ ) SO ₂ (R _c ), wherein R _a , R _b and R _c are as defined above.

In addition, there may be mentioned a preparation method according to the present invention as defined previously for which R ₁ represents:

or an aryl optionally substituted with one or more groups (for example 1 to 3) groups, which are identical or different from one another, chosen from a halogen atom (such as Cl and F), a - (C ₁ -C ₄ JaIkVIe, - (C ₁ - C ₄₎ alkoxy, - (C ^ C ^ perfluoroalkyl, - (C ₁ -C ₄₎ perfluoroalkoxy, -NO _2, - (C ₃ - C ₆₎ optionally substituted heterocycle, -N ( R _a ) (R _b ), -N (R _a ) CO (R _b ), -

OSO ₂ Rc, -COR _b and -COOR _C , wherein R _a and R _b are independently selected from a hydrogen atom, an optionally substituted - (C ₁ -C ₄₎ JaKyIe or (C ₁ -C ₄ ) perfluoroalkyl group and R _c has the values of R ₃ except for hydrogen, - or -SO ₂ -aryl wherein the aryl is optionally substituted by one or more (e.g. 1 to 3) groups, the same or different from each other, selected from a halogen atom, a - (C ₁ -C ₄ JaIKyIe, - (C ₁ - C ₄₎ alkoxy, - (C ₁ -C ₄₎ CJSII IuOrOaIKyIe ^1, - (C ₁ -C ₄₎ perfluoroalkoxy;

or a -SO ₂ -heteroaryl group in which the heteroaryl is optionally substituted by one or more (for example 1 to 3) groups, which are identical to or different from each other, chosen from a halogen atom, a - (C _r -C ₄₎ alkyl, - (C _r C ₄₎ alkoxy, - (C ^ C ^ perfluoroalkyl, - (C ₁ - C ₄₎ perfluoroalkoxy;

or a -SO ₂ - (C ₁ -C ₄ ) perfluoroalkyl group; or a -CO ₂ - (C ₁ -C ₃ ) alkyl group in which the alkyl is optionally substituted by one or more (for example 1 to 3) groups, which are identical or different each other selected from a fluorine atom, a - (C ₁ -C ₄ ) perfluoroalkyl, - (CrC ₄ ) perfluoroalkoxy, optionally substituted aryl, - NO ₂ , -N (R ₃ ) (R _b ) group, -COR _b , -COOR _c , wherein R ₃ , R _b and R _c are as defined above; or a heteroaryl optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from a halogen atom, a - (C ₁ -C ₄₎ JaIKyI, - (C ₁ - C ₄ ) perfluoroalkyl, - (C ₁ -C ₄ ) PeItIuOrOaClOXY, - (C ₁ -C ₄₎ JaCoXy, CN, -COR _b , -COORc, where R _b and R _c are as defined above; (CrCβ) alkyl optionally substituted with one or more (for example 1 to 3) groups, identical or different from each other, selected from a fluorine atom, a - (C ₁ -C ₄ ) perfluoroalkyl, -NO ₂ , - CN group optionally substituted aryl, optionally substituted heteroaryl or -NR _d R _e , where R _d and R _e are H or - (C ₁ -C ₄₎ alkyl.

There may also be mentioned a preparation method according to the present invention as defined above for which R ₁ represents:

or an aryl optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from a halogen atom (such as Cl and F) and a - (CrC ₄ ) alkyl group - (C ₁ -C ₄ ) alkoxy, -CF ₃ , -NO ₂ , -NHCOR _d (with R _d , as defined above), - CO (C ₁ -C ₄ ) alkyl, - (C ₃ -C ₆ ) heterocycloalkyl optionally substituted with one or more groups, identical or different from each other, selected from an oxo group and (C _r C ₂ ) alkyl optionally substituted with a heteroaryl;

or an -SO ₂ -aryl group in which the aryl is optionally substituted with one or more (for example 1 to 3) groups, which are identical to or different from each other, chosen from a halogen atom, a - (C ₁ -C ₄ alkyl, - (C ₁ -C ₄ ) alkoxy, - (C ₁ -C ₄ ) perfluoroalkyl, - (C ₁ -C ₄ ) PeIfIuOrOaClOXy;

or a -SO ₂ -heteroaryl group in which the heteroaryl is optionally substituted by one or more (for example 1 to 3) groups, which are identical to or different from each other, chosen from a halogen atom, a - (C _r -C ₄₎ alkyl, - (C ₁ -C ₄ JaIcOXy, - (dC ^ perfluoroalkyl, - (C ₁ - C ₄₎ perfluoroalkoxy;

- a -S0 ₂ - (C ₁ -C ₄ ) perfluoroalkyl group; or a -CO ₂ - (C ₁ -C ₃ ) alkyl group in which the alkyl is optionally substituted with one or more groups (for example 1 to 3) groups, which are identical to or different from each other, chosen from a fluorine atom; , - (C ₁ -C ₄ ) perfluoroalkyl, - (C ₁ -C ₄ ) perfluoroalkoxy, optionally substituted aryl, NO ₂ , -N (R ₃ ) (R _b ), -COR _b , -COOR _C , where R _a , R _b and R _c are as defined above;

or a heteroaryl optionally substituted with one or more groups (for example 1 to 3) groups, identical or different from one another, chosen from a halogen atom, a - (C ₁ -C ₄ ) alkyl group, - (C ₁ - C ₄ ) perfluoroalkyl, - (C ₁ -C ₄ ) PePfIuOrOaClOXy, - (C ₁ -C ₄₎ JaICOXy,

CN, -COR _b , -COOR _c , wherein R _b and R _c are as previously defined; is an alkyl optionally substituted with one or more (for example 1 to 3) groups, identical or different from each other, selected from a fluorine atom, a - (CrC 4) perfluoroalkyl group (such as -CF ₃ , -CF ₂ CF ₃ ), - NO ₂ , -CN, optionally substituted aryl, optionally substituted heteroaryl or -NR _d R _e , where R _d and R _e are H or - (C _r C ₄ ) alkyl.

Preferably, the present invention relates to a preparation method as defined above for which R ₂ represents a - (C ₁ -C ₂ ) perfluoroalkyl group.

The present invention also preferably relates to a preparation method as defined above for which R ₃ and R ₄ represent, independently of one another, an alkyl or alkoxyalkyl group or else R ₃ and R ₄ together form, with the nitrogen atom to which they are attached, a morpholinyl group.

Preferably, the subject of the present invention is a preparation method as defined above for which R ₅ , R ₆ and R ₇ represent a methyl group.

According to the present invention, the compound of formula (III) is obtained by reaction of the compounds of formula (IV), and (V), preferably in a ratio (IV) / (V) between 1 and 2 equivalents, at a temperature of between -40 ^° C. and 40 ^° C., in the presence of preferably from one to two equivalents, of a tertiary amine (such as triethylamine, N, N-diisopropylethylamine, pyridine, 2,6-lutidine), in an organic solvent preferably a non-polar solvent such as dichloromethane.

According to the present invention, the sulfanylamides of formula (I) and the sulfinamidines of formula (II) are obtained by adding, to the preceding reaction mixture containing the compound of formula (III), a compound of formula RiNH ₂ , preferably an equivalent, at a temperature between -40 ⁰ C and 40 ⁰ C.

When the sulfinamidine intermediate of formula (II) is isolable and stable, it can be converted to the sulfanylamide compound of formula (I) by reaction in an organic solvent such as dichloromethane, in the presence of an organic or inorganic acid, by for example, trifluoroacetic acid, at a temperature between 0 ^° C. and the boiling point of the solvent.

The present invention also relates to the process for preparing a compound of formula (l _b i _S) in which Ro is an alkyl, alkylene, alkynyl, optionally substituted, obtained by alkylation of compounds of formula (I), wherein R ₁ and R ₂ are as defined above. Thus, according to the present invention, the compounds of formula (I) are reacted with an alkylating agent of formula R ₀ X or R ₀ OSO ₂ R, where X is a halogen atom and R is an alkyl or aryl group optionally substituted, in the presence of an organic or inorganic base such as sodium hydride NaH, in a polar aprotic solvent such as dimethylformamide, at a temperature in particular between -20 ^° C. and 60 ^° C.

The present invention also relates to the intermediate compounds of formula (I), (II) and (III):

in which R 1, R ₂ R ₃ and R ₄ are as defined above. The preparation of intermediates of formula (I), (II) and (III)

The sulfanylamides (I), (Ibis) and sulfinamidines (II) according to the invention can find applications in the field of agrochemistry and pharmacy, as substitutes for molecules containing hydrophobic groups fluoroalkyl, fluoroalkoxy, fluoroalkylsulfanyl or fluoroalkylsulfonyl, such as CF ₃ , OCF ₃ , SCF ₃ and SO ₂ CF ₃ by replacing said hydrophobic groups with NR ₀ SR ₂ and N = S (R ₂ ) NR ₃ R _{4 groups} as described in the present invention and with R ₀ , R ₂ , R ₃ and R ₄ defined as above.

By way of non-limiting example, the molecules below are inhibitors of the IGF1-R tyrosine kinase [Baserga, R. Exp. IECI. Res., 1999, 253, 1-6 for a review on this kinase]:

The table below shows that the molecule in which R = NHSCF ₃ , prepared according to the present invention, is comparable, in terms of biochemical and cellular activities, to the molecules described in patent FR2850652 with R = OCF ₃ , SCF ₃ or SO ₂ CF ₃ .

1: HTRF format. 2: Inhibition of autophosphorylation of IGF1-R in cellulo. 3: Inhibition of the proliferation induced by IGF1 of a MEF line.

Sulfanylamides (I) in which R ₁ is of the type -SO ₂ -aryl, -SO ₂ -heteroaryl, -SO ₂ -fluoroalkyl, -CO ₂ -alkyl, -CO ₂ -aryl or -CO ₂ -heteroaryl, where the groups aryl, heteroaryl and alkyl may be optionally substituted, may find applications in the field of pharmacy, as substitutes for molecules containing a carboxylic acid function by replacing said carboxylic acid with a group -SO ₂ -NH-SR ₂ or - OCO-NH-SR ₂ as described in the present invention and with R ₂ defined as above. This replacement is possible in these cases because of the acidic nature of the compounds R ₁ -NH-SR ₂ . By way of non-limiting example, the compound P-CH ₃ -C ₆ H ₄ -SO ₂ -NH-SCF ₃ has a measured pKa of 5.4 (titration with D-Pas in MeOH / KCl 0.15M at 25 ° C. C), while the pKa of benzoic acid is 4.2.

The sulfanylamides (I) or (1 _bιs ) where R ₁ is an aryl group (advantageously phenyl), R ₂ is a trifluoromethyl group and for the compound of formula (1 _bιs ) R ₀ is a methyl group can be used as a perfluoroalkylsulfanylation - preferentially trifluoromethyl- and pentafluoroethyl-sulfanylation of compounds aromatic, heteroaromatic, alkenyl and alkynyl, according to the three equations below.

Thus, the present invention also relates to the use of compounds of formula (I) and _(la) as perfluoroalkylsulfanylation agent compounds aryl, heteroaryl, alkenyl and alkynyl as defined below. According to the invention, the unsaturated substrate and the compound (I), in equimolar quantity, are reacted in the presence of either an excess of sulphonic acid (preferably para-toluenesulphonic acid or camphorsulphonic acid) or of hydrochloric acid in ether, either an excess of a sulphonic acid salt (preferably the sodium salt of para-toluenesulphonic acid) and a Lewis acid (such as ethyl trifluoroborate). ), in an apolar solvent such as dichloromethane and at a temperature between 0 ° and 40 ⁰ C, to give compounds having an SR ₂ function.

The resulting polyfluorinated compounds are potentially interesting compounds for various applications, including agrochemistry and pharmacy, for example as building blocks for building more complex bioactive molecules. The starting compounds and reagents, when their method of preparation is not described below, are commercially available or described in the literature or may be prepared according to methods described therein or which are known in the art. 'Man of the art. The invention is also described by the following examples, given by way of illustration of the invention.

Example 1: 5,5-Dimethyl-1-quinolin-4-ylmethyl-3- (4-trifluoromethyl-sulfanylaminophenyl) imidazolidine-2,4-dione, trifluoroacetate (Compound 1)

1.1: 3- (4-nitro-phenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione

To a solution of 1.000 g of 2-methyl-2 - [(quinolin-4-ylmethyl) -amino] propionic acid methyl ester (prepared according to the process described in patent application FR2850652), in 40 ml of tetrahydrofuran, at a temperature in the region of 20 ° C., is added 1,600 g of 4-nitrophenyl isocyanate. The mixture obtained is stirred at this same temperature for 18 hours. 20 ml of methanol are then added and the mixture is stirred for 15 minutes at room temperature. The resulting solution is concentrated under reduced pressure to give a yellow powder which is taken up in 150 ml of methanol. The suspension obtained is filtered on sintered glass to give 1,400 g of 3- (4-nitro-phenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione, in the form of bright yellow powder (MS: M ⁺ = 391 g / mol).

1.2: 3- (4-amino-phenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione

To a mixture of 1.35 g of 3- (4-nitro-phenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione and 0.130 g of 5% palladium on Charcoal in 70 ml of ethanol, at a temperature in the region of 55 ° C., 4.4 ml of hydrazine hydrate are added dropwise. The resulting reaction mixture is then stirred at this same temperature for 3 h 30, then cooled and filtered on celite. The filtrate obtained is concentrated under reduced pressure to give 1,180 g of 3- (4-aminophenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione in powder form. greyish white (MS: M ⁺ = 360 g / mol).

1.3: 5,5-Dimethyl-1-quinolin-4-ylmethyl-3- (4-trifluoromethyl-sulfanylamino-phenyl) imidazolidine-2,4-dione, trifluoroacetate 0.25 g of diethylaminosulfur trifluoride (DAST) are added dropwise to a solution of 0.260 g of β-diisopropylethylamine in 15 ml of dichloromethane under an inert atmosphere of argon and at a temperature in the region of -20 ^° C. ). The mixture obtained is stirred at this same temperature for 10 minutes and then cooled to -20 ^° C. before addition of 0.150 ml of (trifluoromethyl) trimethylsilane and stirring at -20 ^° C. for 1 hour. To the resulting mixture was slowly added a suspension of 0.360 g of 3- (4-amino-phenyl) -5,5-dimethyl-1-quinolin-4-ylmethylimidazolidine-2,4-dione in 5 ml of acetate. of ethyl and 5 ml of dichloromethane. The mixture is then stirred for 3 hours at 0 ^° C. and then 48 hours at room temperature, before adding a saturated solution of sodium hydrogencarbonate. The organic phase is separated, dried over magnesium sulfate, filtered and concentrated under reduced pressure. The residue obtained is dissolved in 50 ml of dichloromethane. 0.500 ml of trifluoroacetic acid are added dropwise at room temperature and the resulting mixture is left at the same temperature for 18 hours. The solution is then concentrated under reduced pressure and the residue obtained is purified by preparative LC / MS (gradient water / acetonitrile 0.07% trifluoroacetic acid). 0.010 g of 5,5-dimethyl-1-quinolin-4-ylmethyl-3- (4-trifluoromethylsulfanylamino-phenyl) imidazolidine-2,4-dione, trifluoroacetate are thus obtained in the form of a light beige powder (yield 2%; MS M ⁺ = 461 g / mol).

¹ H-NMR (300 MHz, DMSO d6): δ ppm 8.90 (bd, 1H); 8.50 (s, 1H); 8.29 (bd, 1H); 8.10 (broad d, 1H); 7.85 (broad t, 1H); 7.72 (bt, 1H); 7.64 (d, 1H); 7.36 (bd, 2H); 7.20 (broad d, 2H); 5.15 (brs, 2H); 1, 42 (broad s, 6H).

Example 2: 4-Methyl-N - [(trifluoromethyl) thio] benzenesulfonamide (Compound 21)

2.1: Λ / - [difluoro (trifluoromethyl) -l ⁴ -sulfanyl] -Λ /, Λ / -diethylamine

0.135 ml of DAST are added dropwise to a solution of 0.130 g of β-, β-diisopropylethylamine in 2 ml of anhydrous dichloromethane, under an inert atmosphere of nitrogen and at a temperature in the region of -20 ^° C. The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.150 ml of (trifluoromethyl) trimethylsilane. After 1 hour, with stirring at -20 ^° C., a ¹⁹ F NMR assay of the reaction medium is carried out. The compound Λ / - [difluoro (trifluoromethyl) -l- ⁴ -sulfanyl] -α, β-diethylamine, not isolated, was produced quantitatively.

¹⁹ F NMR (282 MHz, CFCI ₃ ): δ ppm + 2.31 (q, 2F); -64.81 (t, 3F). 2.2 Λ / - [(diethylamino) (trifluoromethyl) -N- ^4- sulfanylidene] -4-methylbenzenesulfonamide (Compound 37)

To the reaction mixture of step 2.1, 0.171 g of A-methylbenzenesulfonamide dissolved in 2 ml of anhydrous ethyl acetate are added at -20 ° C. The reaction medium is then stirred at room temperature for 18 hours. The reaction crude is subsequently washed with an aqueous solution (6%) of NaHCO ₃ before being dried over Na ₂ SO ₄ . The organic phase is concentrated and purified by chromatography on silica in the presence of 0.5% triethylamine (pentane / acetone: 8/1). 0.325 g of the expected product is obtained in the form of a yellow oil (yield 95%, LC / MS M + = 342 g / mol).

2.3: 4-methyl-N - [(trifluoromethyl) thio] benzenesulfonamide (Compound 21)

To a solution of 0.342 g Λ / - [(diethylamino) (trifluoromethyl) -λ ⁴ -sulfanylidene] -

4-methylbenzenesulfonamide in 2 ml of dichloromethane is added 0.260 ml of trifluoroacetic acid at room temperature. The reaction medium is subsequently stirred at 50 ^° C. for 24 hours. Finally, the crude reaction product is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure, 0.260 g of 4-methyl-N - [(trifluoromethyl) thio] benzenesulphonamide is obtained in the form of a white powder (yield 96%, LC / MS M + = 271 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.81 (d, 2H); 7.35 (d, 2H); 6.75 (brs, 1H); 2.45 (s, 3H).

Example 3: 1- (4 - {[(trifluoromethyl) thio] amino} phenyl) ethanone (Compound 18)

3.1: 4- [difluoro (trifluoromethyl) -l ⁴ -sulfanyl] morpholine

0.137 ml of morpholinosulfur trifluoride are added dropwise to a solution of 0.130 g of β-diisopropylethylamine in 2 ml of anhydrous dichloromethane, under an inert atmosphere of nitrogen and at a temperature in the region of -20 ° C. The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.150 ml of trifluoromethyltrimethylsilane. After 1 hour, with stirring at -20 ° C, a ¹⁹ F NMR assay of the reaction medium is carried out. The 4- [difluoro (trifluoromethyl) -l ⁴ -sulfanyl] morpholine compound, not isolated, was quantitatively produced. ¹⁹ F NMR (282 MHz, CFCI ₃ ): δ ppm + 2.66 (q, 2F); -63.72 (t, 3F). 3.2: 1- (4 - {[Morpholin-4-yl (trifluoromethyl) -N- ^4- sulfanylidene] amino} phenyl) ethanone (Compound 36)

0.135 g of 1- (4-aminophenyl) ethanone in solution in 2 ml of anhydrous dichloromethane are added to the reaction mixture of step 3.1 at -20 ^° C. The reaction medium is then stirred at room temperature for 4 hours. The reaction crude is subsequently washed with an aqueous solution (6%) of NaHCO ₃ before being dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (Pentane / acetone: 4/1), 0.224 g of 1- (4 - {[morpholin-4-yl (trifluoromethyl) -l- ^4- sulfanylidene] are obtained. amino} phenyl) ethanone as a white powder (yield 70%, LC / MS M + = 320 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.81 (d, 2H); 7.35 (d, 2H); 6.75 (brs, 1H); 2.45 (s, 3H).

3.3: 1- (4 - {[(trifluoromethyl) thio] amino} phenyl) ethanone (Compound 18)

At a temperature of 0 ° C., 0.090 ml of trifluoroacetic acid is added dropwise to a solution of 0.320 g of compound obtained in step 3.2 in 2 ml of dichloromethane. The reaction medium is subsequently stirred at room temperature for 12 hours. Finally, the crude reaction product is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure, the residue is purified by chromatography on silica (Pentane / acetone: 60/1) to give 0.207 g.

{[(trifluoromethyl) thio] amino} phenyl) ethanone in the form of a beige powder (yield 88%, LC / MS M + = 235 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.91 (d, 2H); 7.16 (d, 2H); 6.11 (bs, 1H); 2.56 (s, 3H).

Example 4: 1- (4 - {[(trifluoromethyl) thio] amino} phenyl) ethanone (Compound 18)

Alternatively to Example 3, 1- (4 - {[(trifluoromethyl) thio] amino} phenyl) ethanone can be prepared according to the following procedure: to the reaction mixture of step 2.1, it is added at -20 ° C, 0.135 g of 1- (4-aminophenyl) ethanone dissolved in 2 ml of anhydrous dichloromethane. The reaction medium is then stirred at room temperature for 4 hours before being washed with an aqueous solution (6%) of NaHCO ₃ and dried over Na ₂ SO ₄ . After filtration and evaporation under reduced pressure, the crude The reaction mixture is solubilized in 2 ml of anhydrous dichloromethane and then cooled to a temperature of 0 ^° C. 0.070 ml of trifluoroacetic acid is then added dropwise and the reaction mixture is stirred at room temperature for 1 hour. Finally, the crude reaction product is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and washing with pentane, 0.164 g of 1- (4- {[(trifluoromethyl) thio] amino} phenyl) ethanone are obtained in the form of a beige-colored powder (yield 70%; LC / MS). M + = 235 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.91 (d, 2H); 7.16 (d, 2H); 6.11 (bs, 1H); 2.56 (s, 3H).

Example 5 Benzyl [(trifluoromethyl) thio] carbamate (Compound 22)

5.1: Benzyl [diethylamino (trifluoromethyl) -l ⁴ -sulfanylidene] carbamate (Compound 42)

To the reaction mixture of step 2.1, 0.151 g of benzyloxycarbamate dissolved in 2 ml of anhydrous dichloromethane is added at -20 ^° C. The reaction medium is then stirred at room temperature for 48 hours. The reaction crude is subsequently washed with an aqueous solution (6%) of NaHCO ₃ before being dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (Pentane / acetone: 15/1), 0.222 g of benzyl [(1Z) - (diethylamino) (trifluoromethyl) -l ⁴ -sulfanylidene] carbamate are obtained in the form a yellow oil (Yield 69%, LC / MS M + = 322 g / mol).

5.2: Benzyl [(trifluoromethyl) thio] carbarnate (Compound 22)

To a solution of 0.322 g of benzyl [diethylamino (trifluoromethyl) -l- ⁴ -sulfanylidene] carbamate dissolved in 2 ml of dichloromethane is added 0.260 ml of trifluoroacetic acid at room temperature. The reaction medium is subsequently stirred at 50 ^° C. for 24 hours. Finally, the crude reaction product is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and washing with diethyl ether, 0.201 g of benzyl [(trifluoromethyl) thio] carbamate in the form of orange powder (yield 80%, LC / MS M + = 251 g / mol) is obtained.

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.43-7.39 (solid, 5H); 6.15 (bs, 1H); 5.42 (s, 2H).

Example 6: 4-Nitro-Λ / - [(trifluoromethyl) thio] aniline (Compound 17) 6.1: N, N-diethyl-1,1,1-trifluoro-N '- (4-nitrophenyl) methane sulfinimidamide (Compound 33)

To the reaction mixture of step 2.1, 0.175 ml of N, N-diisopropylethylamine is added at -20 ^° C. and then, 5 minutes later, against the stream of N ₂ , 0.140 g of 4-nitroaniline. The reaction medium is subsequently stirred at 0 ° C. for 3 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over

Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product in the presence of 0.5% triethylamine (Pentane / acetone:

30/1), 0.247 g of N, N-diethyl-1,1,1-trifluoro-N - (4-nitrophenyl) methanesulfinimidamide are obtained in the form of a brown-colored oil (yield 80%). LC / MS M + = 309 g / mol).

6.2: 4-nitro-Λ / - [(trifluoromethyl) thio] aniline (Compound 17)

At a temperature of 0 ° C., 0.090 ml of trifluoroacetic acid is added dropwise to a solution of 0.309 g of compound obtained in step 6.1 in 2 ml of dichloromethane. The reaction medium is subsequently stirred at room temperature for 1 h. Finally, the crude reaction product is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure, 0.238 g of 4-nitro-β- [(trifluoromethyl) thio] aniline is obtained in the form of a brown powder. The yield is quantitative (LC / MS M + = 238 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 8.22 (m, 2H); 7.20 (m, 2H); 5.64 (bs, 1H).

Example 7: Λ / - {[1,3-benzoxazol-2-yl (difluoro) methyl] thio} -1-phenylmethanamine (Compound 8)

7.1: Λ- {[1,3-benzoxazol-2-yl (difluoro) methyl] (difluoro) -l- ^4- sulfanyl} -α, Λ-diethylamine

0.135 ml of diethylaminosulfur trifluoride are added dropwise to a solution of 0.130 g of β-diisopropylethylamine in 2 ml of anhydrous dichloromethane, under an inert nitrogen atmosphere and at a temperature of -20 ^° C. The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.241 g of 2- [difluoro (trimethylsilyl) methyl] -1,3-benzoxazole. After 1 hour, with stirring at room temperature, a ¹⁹ F NMR assay of the reaction medium is carried out. The compound Λ / - {[1,3-benzoxazol-2-yl (difluoro) methyl] (difluoro) -l- ^4- sulfanyl} - Λ /, Λ-diethylamine, not isolated, was produced quantitatively. ¹⁹ F NMR (282 MHz, CFCI ₃ ):? Ppm-0.92 (m, 2 F); -91, 06 (m, 3F).

7.2: Λ / - {[1,3-benzoxazol-2-yl (difluoro) methyl] thio} -1-phenylmethanamine (Compound 8)

At room temperature, 0.110 ml of benzylamine is added dropwise to the reaction mixture of step 7.1. The reaction medium is subsequently stirred at ambient temperature for 24 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (pentane / ethyl acetate: 40/1), 0.107 g of Λ / - {[1,3-benzoxazol-2-yl (difluoro) methyl) are obtained. ] thio} -1-phenylmethanamine in the form of a white powder (yield 35%, LC / MS M + = 306 g / mol).

¹ H-NMR (300MHz ₁ CDCl _3): δ ppm 7.86 (m, 1H); 7.64 (m, 1H); 7.53-7.44 (solid, 2H); 7.40-7.26 (solid, 5H); 4.28 (d, 2H); 3.27 (brs, 1H).

Example 8: N '- {3-cyano-1- [2,6-dichloro-4- (trifluoromethyl) phenyl] -1H-pyrazol-5-yl} - Λ], 1,1-diethyl-1,1 2,2,2-pentafluoroethane sulfinimidamide (Compound 25)

8.1: Λ / '- [difluoro (pentafluoroethyl) -l ⁴ -sulfanyl] -Λ /, Λ-diethylamine

0.135 ml of diethylaminosulfur trifluoride are added dropwise to a solution of 0.130 g of β-diisopropylethylamine in 2 ml of anhydrous dichloromethane under an inert atmosphere of nitrogen and at a temperature in the region of -20 ° C. ( DAST). The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.180 ml of (pentafluoroethyl) trimethylsilane. After 1 hour, with stirring at -20 ^° C., a ¹⁹ F NMR assay of the reaction medium is carried out. The compound Λ / '- [difluoro (pentafluoroethyl) -α- ^4- sulfanyl] -α, Λ-diethylamine, not isolated, was produced quantitatively.

¹⁹ F NMR (282 MHz, CFCI ₃ ): δ ppm + 3.32 (m, 2 F); -78.52 (t, 3F); -106.18 (m, 2F).

8.2: N- (3-cyano-1- [2,6-dichloro-4- (trifluoromethyl) phenyl] -1H-pyrazol-5-yl} -1H-diethyl-1,1,1-diol; 2,2,2-pentafluoroethane sulfinimidamide (Compound 25)

At a temperature of -20 ° C., 0.322 g of 1- (2,6-dichloro-4-trifluoromethylphenyl) -3-cyano-5-aminopyrazole in solid form is added in the countercurrent of N ₂ to the reaction mixture. step 8.1. The reaction medium is then stirred at room temperature during 48h. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and washing with pentane, 0.04 g of N- (3-cyano-1- [2,6-dichloro-4- (trifluoromethyl) phenyl] -1H-pyrazol-5-yl are obtained. -Λ /, Λ-diethyl-1,1,2,2,2-pentafluoroethane sulfinimidamide in the form of a brown powder (yield 10%, LC / MS M + = 542 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.69 (m, 2H); 5.90 (s, 1H); 3.40 (m, 4H); 1, 23 (t, 6H).

Example 9: N, N-diethyl- / V '- [(pentafluoroethyl) thio] pentane-1,4-diamine (Compound 7)

At a temperature of -20 ^° C., 0.200 ml of N ₁ N-diethylpentane-1,4-diamine is added dropwise to the reaction mixture of step 8.1. The reaction medium is subsequently stirred at ambient temperature for 4 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (Pentane / acetone: 1/1), 0.062 g of Λ /, Λ-diethyl-β- [(pentafluoroethyl) thio] pentane-1 are obtained. 4-diamine as a colorless oil (Yield 20%, LC / MS M + = 308 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 3.34 (br s, 1H); 3.05 (m, 1H); 2.60 (q, 4H); 2.49 (t, 2H); 1, 55-1, 44 (massive, 4H); 1, 16 (d, 3H); 1, 07 (t, 6H).

Example 10: Λ / - [(trifluoromethyl) thio] aniline (Compound 9)

At a temperature of -20 ^° C., 0.091 ml of aniline is added dropwise to the reaction mixture of step 2.1. The reaction medium is subsequently stirred at room temperature for 12 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the reaction crude

(Pentane / acetone: 60/1), 0.156 g of Λ- [(trifluoromethyl) thio] aniline is obtained in the form of a yellow oil (yield 81%, LC / MS M + = 193 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.35 (m, 2H); 7.15 (m, 2H); 7.06 (m, 1H); 5.09 (bs, 1H).

Example 11: 4-Chloro-N - [(trifluoromethyl) thio] aniline (Compound 11) At a temperature of -20 ^° C., 0.127 g of 4-chloroaniline is added to the reaction mixture of step 2.1 in the counterflow of N ₂ . The reaction medium is subsequently stirred at room temperature for 12 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (pentane / ethyl acetate: 50/1), 0.150 g of 4-chloro-Λ [- [(trifluoromethyl) thio] aniline in the form of a yellow oil (Yield 66%, LC / MS M + = 227 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.26 (d, 2H); 7.04 (d, 2H); 5.14 (brs, 1H).

Example 12 Benzyl (4 - {[(trifluoromethyl) thio] amino} phenyl) carbamate (Compound 19)

To the reaction mixture of step 2.1, 0.175 ml of N ₁ N-diisopropylethylamine is added at 20 ^° C., then 5 minutes later, against a current of N ₂ , 0.242 g of benzyl (4-aminophenyl) carbamate. The reaction medium is subsequently stirred at 0 ^° C. for 3 hours before being washed with an aqueous solution (6%) of NaHCO ₃ and dried over Na ₂ SO ₄ . After filtration and evaporation under reduced pressure, the crude reaction product is solubilized in 2 ml of anhydrous dichloromethane and then cooled to a temperature of 0 ^° C. 0.030 ml of trifluoroacetic acid is then added dropwise.

After 1 hour, with stirring at room temperature, the reaction medium is washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (Pentane / acetone: 8/1), 0.150 g of benzyl (4 - {[(trifluoromethyl) thio] amino} phenyl) carbamate is obtained in the form of a brown powder (Yield 44%, LC / MS M + = 342 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.41-7.26 (solid, 7H); 7.01 (m, 2H); 6.68 (bs, 1H); 5.19 (s, 2H); 5.14 (bs, 1H).

Example 13: ΛT- {3-cyano-1- [2,6-dichloro-4- (trifluoromethyl) phenyl] -1H-pyrazol-5-yl} -1,1,1-trifluoro-Λ / Λ / bis (2-methoxyethyl) methane sulfinimidamide (Compound 27)

13.1: Λ- [Difluoro (trifluoromethyl) -N- ^4- sulfanyl] -bis (2-methoxyethyl) amine

To a solution of 0.130 g of N, N-diisopropylethylamine in 2 ml of anhydrous dichloromethane, under an inert atmosphere of nitrogen and at a temperature in the region of -20 ^° C., 0.468 ml of a solution is added dropwise. 50% molar commercial bis trifluoride (methoxyethyl) aminosulfur (Deoxofluor ^®) in tetrahydrofuran. The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.150 ml of (trifluoromethyl) trimethylsilane. After stirring for 1 hour at -20 ^° C., a ¹⁹ F NMR determination of the reaction medium is carried out. The N- [difluoro (trifluoromethyl) -l ⁴ -sulfanyl] -bis (2-methoxyethyl) amine compound, not isolated, was produced quantitatively.

¹⁹ F NMR (282 MHz, CFCI ₃ ): δ ppm + 2.04 (q, 2F); -65.53 (t, 3F).

13.2: Λ- (3-cyano-1- [2,6-dichloro-4- (trifluoromethyl) phenyl] -1H-pyrazol-5-yl} -1,1,1-trifluoro-Λ, Λ / bis (2-methoxyethyl) methane sulfinimidamide (Compound 27)

At a temperature of -20 ^° C., 0.322 g of 1- (2,6-dichloro-4-trifluoromethylphenyl) -3-cyano-5-aminopyrazole in solid form are added in the solid state to the reaction mixture of N _2. step 13.1. The reaction medium is then stirred at room temperature for 18 h. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the crude reaction product (pentane / acetone: 10/1), 0.429 g of Λ '- {3-cyano-1- [2,6-dichloro-4- ( trifluoromethyl) phenyl] -1H-pyrazol-5-yl} -1,1,1-trifluoro-β, β-bis (2-methoxyethyl) methanesulphinimidamide in the form of a viscous yellow oil (yield 78 % LC / MS M + = 552 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.69 (s, 2H); 6.15 (s, 1H); 3.58-3.42 (solid, 8H); 3.33 (s, 6H).

Example 14: Λ / - {[difluoro (phenylthio) methyl] thio} aniline (Compound 14)

14.1: Λ / '- {[difluoro (phenylthio) methyl] (difluoro) -λ ⁴ -sulfanyl} -Λ /, Λ / -diethyl-amine

0.135 ml of diethylaminosulfur trifluoride is added dropwise to a solution of 0.130 g of β-diisopropylethylamine in 2 ml of anhydrous dichloromethane under an inert atmosphere of nitrogen and at a temperature in the region of -20 ^° C.

(DAST). The reaction medium is stirred at this same temperature for 10 minutes before the addition of 0.232 g of [difluoro (phenylthio) methyl] trimethylsilane. After 1 hour, with stirring at -20 ^° C., a ¹⁹ F NMR assay of the reaction medium is carried out. The compound N - {[difluoro (phenylthio) methyl] (difluoro) -l ⁴ -sulfanyl} -α, Λ-diethylamine, not isolated, was produced quantitatively.

¹⁹ F NMR (282 MHz, CFCI ₃ ): δ ppm -0.44 (m, 2F); -63.02 (m, 2F). 14.2: Λ / - {[difluoro (phenylthio) methyl] thio} aniline (Compound 14)

At a temperature of -20 ⁰ C ₁ is added dropwise 0.091 ml of aniline to the reaction mixture of step 14.1. The reaction medium is subsequently stirred at room temperature for 48 hours. Finally, the crude reaction product is washed with an aqueous solution (6%) of NaHCO ₃ and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure and purification by chromatography on silica of the reaction crude

(Pentane / acetone: 60/1), 0.158 g of N- {[difluoro (phenylthio) methyl] thio} aniline is obtained in the form of a colorless oil (Yield 56%; LC / MS

M + = 283 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.69 (m, 2H); 7.55-7.42 (solid, 3H); 7.24 (m, 2H); 7.00-6.92 (solid, 3H); 5.23 (bs, 1H).

Example 15: N-methyl-N - [(trifluoromethyl) thio] aniline (Compound 43)

To a solution, cooled to -10 ^° C., 0.193 g of N - [(trifluoromethyl) thio] aniline (Compound 9, Example 10) in 2 ml of anhydrous dimethylformamide is added 0.048 g of NaH with vigorous stirring. The resulting mixture is maintained for 10 minutes at -100 ^° C. before the introduction of 0.075 ml of iodomethane, drop by drop. The reaction medium is then left stirring at room temperature for 4 hours. The mixture obtained is then taken up in a Pentane / H ₂ O mixture. The organic phase is separated, dried over Na ₂ SO ₄ and then concentrated in vacuo to give a residue which is purified by chromatography on silica (pentane). 0.172 g of N-methyl-N - [(trifluoromethyl) thio] aniline is obtained in the form of a colorless oil (yield 83%, LC / MS M + = 207 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.34-7.22 (solid, 4H); 6.97 (m, 1H); 3.50 (s, 3H).

Example 16: Λ / - [(trifluoromethyl) thio] - V-undecylaniline (Compound 46)

To a solution, cooled to -10 ° C., 0.13 g of Λ- [(trifluoromethyl) thio] aniline (Compound 9, Example 10) in 2 ml of anhydrous dimethylformamide, is added 0.048 g of NaH with vigorous stirring. The resulting mixture was held for 10 minutes at -10 ° C before the introduction of 0.278 ml of 1-iodoundecane dropwise. The reaction medium is then left stirring at room temperature for 4 hours. The mixture obtained is taken up in a Pentane / H ₂ O mixture. The organic phase is separated, dried over Na ₂ SO ₄ and then concentrated in vacuo to give a residue which is purified by chromatography on silica (Pentane). 0.264 g of N- [(trifluoromethyl) thio] -Λ-undecylaniline is obtained in the form of a colorless oil (yield 76%, LC / MS M + = 347 g / mol). ¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.33-7.22 (solid, 4H); 6.97 (m, 1H); 3.73 (m wide, 2H); 1.72 (m, 2H); 1, 33-1, 28 (massive, 16H); 0.9 (t, 3H).

The use of the compounds obtained according to the present invention as a perfluoroalkylsulfanylation agent for aromatic, heteroaromatic, alkenyl and alkynyl compounds is also described by the following examples:

Example 17: (1R ^* , 2R ^* ) -2 - [(trifluoromethyl) thio] cyclohexyl-4-methylbenzene sulfonate (Compound 68)

To a solution of 0.193 g of Λ- [(trifluoromethyl) thio] aniline (Compound 9, Example 10) in 2 ml of dichloromethane is added 0.102 ml of cyclohexene and then, 5 minutes later, 0.475 g of para-acid is added. -toluenesulphonic monohydrate in solid form. The reaction medium is then heated for 18 h at 50 ° C. The crude reaction product is finally washed with water and then dried over Na ₂ SO ₄ . After evaporation under reduced pressure, the residue is purified by chromatography on silica (pentane / acetone: 80/1). 0.276 g of (1R ^* , 2R ^* ) -2 - [(trifluoromethyl) thio] cyclohexyl-4-methylbenzenesulfonate are obtained in the form of a yellow powder (Yield 78%, LC / MS

M + = 354 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.80 (d, 2H); 7.35 (d, 2H); 4.49 (ddd, 1H); 3.29 (ddd, 1H); 2.44 (s, 3H); 2.22 (m, 1H); 2.03 (m, 1H); 1, 69-1, 65 (solid, 3H); 1, 48-1.44 (massive, 3H).

Example 18: (1 R ^* , 2R ^* ) -1-Propyl-2 - [(trifluoromethyl) thio] pentyl-4-methylbenzene sulfonate (Compound 61)

To a solution of 2 ml of dichloromethane containing 0.207 g of Λ / -methyl-Λ / -

[(trifluoromethyl) thio] aniline (Compound 43, Example 15), 0.112 g of (Z) -oct-4-ene and 0.291 g of sodium salt of para-toluenesulfonic acid, are added dropwise and with vigorous stirring, 0.635 ml of a commercial solution of BF ₃ -Et ₂ O at 48%. The resulting mixture is then stirred for 4 hours at room temperature and then diluted with Et ₂ O / H ₂ O. The organic phase is separated, washed twice with a 2N HCl solution, dried over Na ₂ SO ₄ then concentrated under vacuum. The residue is purified by chromatography on silica (Pentane / acetone: 100/1) to give 0.246 g of (1 R ^* , 2R ^* ) -1-propyl-2 - [(trifluoromethyl) thio] pentyl-4-methylbenzenesulfonate, in the form of a colorless oil (Yield 64%, LC / MS M + = 384 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.81 (m, 2H); 7.37 (m, 2H); 4.68 (dt, 1H); 3.30 (dt, 1H); 2.45 (s, 3H); 1, 80-1, 48 (massive, 4H); 1, 38-1, 24 (massive, 3H); 1, 12 (m, 1H); 0.86 (t, 3H); 0.81 (t, 3H). Example 19: (1R, 2R ^* ) -2-chlorocyclohexyltrifluoromethyl sulfide (Compound 74)

In a solution of 1 ml of dichloromethane containing 0.193 g of N- [(trifluoromethyl) thio] aniline (Compound 9, Example 10), 0.101 ml of cyclohexene is added. After 5 minutes, 1 ml of a 2N hydrochloric acid solution in diethyl ether is added dropwise. The reaction medium is then stirred at room temperature for 2 hours. The crude reaction product is finally extracted with Et ₂ O / H ₂ O. The organic phase is separated off, dried over Na ₂ SO ₄ and then concentrated under vacuum to give 0.205 g of (1 R ^* , 2R ^* ) -2-chlorocyclohexyltrifluoromethylsulphide. (Yield 94%, LC / MS M + = 218 g / mol).

¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 4.10 (m, 1H); 3.45 (m, 1H); 2.39 (m, 1H); 2.22 (m, 1H); 1, 86-1, 67 (solid, 3H); 1, 62-1, 38 (solid, 3H).

Example 20: 1 - {[(trifluoromethyl) thio] methylene} heptyl-4-methyl-benzenesulfonate (Compound 79)

To a solution of 2 ml of dichloromethane containing 0.207 g of N-methyl-N - [(trifluoromethyl) thio] aniline (Compound 43, Example 15), 0.152 ml of oct-1-yne and 0.291 g of tosylate of sodium hydroxide in 2 ml of dichloromethane are added dropwise with vigorous stirring, 0.635 ml of a commercial solution of BF ₃ -Et ₂ O at 48%. The reaction medium is then stirred for 48 hours at room temperature. The reaction crude is then taken up in an Et ₂ O / H ₂ O mixture before being washed twice with a 2N HCl solution. The organic phase is dried over Na ₂ SO ₄ and 0.170 g of 1 - {[(trifluoromethyl) thio] methylene} heptyl-4-methylbenzenesulphonate is obtained after purification by chromatography on silica (Pentane / acetone: 100/1) of crude reaction (Yield 41%, LC / MS M + = 414 g / mol).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.80 (m, 2H); 7.37 (m, 2H); 5.87 (s, 1H); 2.47 (s, 3H); 2.38 (t, 2H); 1.42 (m, 2H); 1, 32-1, 17 (solid, 6H); 0.86 (t, 3H).

Example 21: 3 - [(trifluoromethyl) thio] indole (Compound 80) In a solution of 2 ml of dichloromethane containing 0.193 g of N- [(trifluoromethyl) thio] aniline (Compound 9, Example 10) is added 0.117 g of indole. After 5 minutes, 0.485 g of para-toluenesulphonic acid monohydrate is added and the reaction mixture is then heated for 18 hours at 50 ^° C. The reaction crude is finally extracted with an Et ₂ O / H ₂ O mixture. The organic phase is separated, dried over Na ₂ SO ₄ and then concentrated under vacuum. The residue is purified by chromatography on silica (Pentane / acetone: 20/1) to give 0.156 g of 3 - [(trifluoromethyl) thio] indole (Yield 72%, LC / MS M ⁺ = 217 g / mol). ¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 8.56 (bs, 1H); 7.80 (m, 1H); 7.53 (d, 1H);

7.42 (m, 1H); 7.32-7.24 (massive, 2H).

Example 22: 2,4-Dimethoxy - [(trifluoromethyl) thio] benzene (Compound 88)

In a solution of 2 ml of dichloromethane containing 0.193 g of N-

[(trifluoromethyl) thio] aniline (Compound 9, Example 10) is added 0.134 g of 1,3-dimethoxybenzene. After 5 minutes, 0.485 g of para-toluenesulphonic acid monohydrate is added and the reaction mixture is then heated for 18 hours at 50 ^° C. The reaction crude is finally extracted with an Et ₂ O / H ₂ O mixture. The organic phase is separated, dried over Na ₂ SO ₄ and then concentrated under vacuum. The residue is purified by chromatography on silica (Pentane / acetone: 200/1) to give 0.214 g of 2,4-dimethoxy - [(trifluoromethyl) thio] benzene (Yield 90%, LC / MS M + = 238 g / mol ).

¹ H NMR (300 MHz, CDCl ₃ ): δ ppm 7.53 (m, 1H); 6.54-6.50 (massive, 2H); 3.88 (s, 3H); 3.83 (s, 3H).

Example 23: 2 - [(trifluoromethyl) thio] -1,2,3,4-tetrahydronaphthalene (Compound 77)

In a solution of 2 ml of dichloromethane containing 0.193 g of N- [(trifluoromethyl) thio] aniline (Compound 9, Example 10), 0.150 ml of 4-phenylbut-1-ene is added. After 5 minutes, 0.180 ml of triflic acid is added dropwise. The reaction medium is then stirred at ambient temperature for 24 hours. The crude reaction product is finally extracted with a mixture Et ₂ O / H ₂ O. The organic phase was separated, dried over Na ₂ SO ₄ then concentrated in vacuo. The residue is purified by chromatography on silica (Pentane / acetone: 80/1) to give 0.165 g of 2 - [(trifluoromethyl) thio] -1,2,3,4-tetrahydronaphthalene (Yield 71%; LC / MS M + = 232 g / mol). ¹ H-NMR (300 MHz, CDCl ₃ ): δ ppm 7.16-7.05 (solid, 4H); 3.69 (m, 1H); 3.27 (m, 1H); 3.04-2.86 (solid, 3H); 2.30 (m, 1H); 1.98 (m, 1H).

The following tables illustrate the chemical structures and the physical properties of some compounds of formula (I), formula (II) and formula (I _b i _S ) according to the invention.

In these paintings:

in the column PF (melting point), "-" represents an oil at ambient temperature, and

- "Me" and "And" respectively represent methyl and ethyl groups.

Table I

The compounds 1 to 23 below were prepared from the intermediate compounds III (themselves prepared according to the step or example indicated), either directly or after reaction with trifluoroacetic acid (TFA), as indicated.

Table II

Compounds 24 to 42 below were prepared from intermediate compounds III according to the steps or examples indicated.

Board

Compounds 43 to 60 were prepared according to Examples 15 and 16.

Table IV: Examples of perfluoroalkylsulfanylation according to the present invention

Compounds 61 to 88 were prepared according to the indicated examples.

,

Claims

A process for preparing the sulfanylamide compound of formula (I) and the sulfinamidine compound of formula (II) in which a) R ₁ represents: or an optionally substituted aryl; or an optionally substituted heteroaryl; or an optionally substituted alkyl; or an optionally substituted cycloalkyl; an optionally substituted heterocycloalkyl; or an -SO ₂ -aryl group in which the aryl is optionally substituted; or a -S0 ₂ -heteroaryl group in which the heteroaryl is optionally substituted; or a -SO ₂ -fluoroalkyl group; or a -CO ₂ -aryl group in which the aryl is optionally substituted; or a -CO ₂ -heteroaryl group in which the heteroaryl is optionally substituted; or a -CO ₂ -alkyl group in which the alkyl is optionally substituted; b) R ₂ represents a perfluoroalkyl or difluoromethylene group substituted with an optionally substituted -S-aryl, -S-heteroaryl or benzoxazol-2-yl group, c) R ₃ and R ₄ represent, independently of one another, an alkyl, alkoxyalkyl or cycloalkyl group, or else R ₃ and R ₄ together with the nitrogen atom to which they are attached form a saturated or unsaturated heterocycle; 3- to 7-membered ring optionally comprising another heteroatom (such as piperidinyl, pirrolidinyl or morpholinyl); characterized in that the following steps are carried out: - a ^1st step, wherein the compound of formula (IV) is condensed with a compound of formula (V) in the presence of a tertiary amine in an organic solvent to give the compound of formula (III), wherein R ₁ , R ₂ , R ₃ and R ₄ are as defined above and R ₅ , R ₆ and R ₇ independently of one another represent a group selected from optionally substituted alkyl or aryl groups; - a ^2nd stage, wherein the compound of formula (III) is itself fused to a compound of formula Rinh _2, wherein R ₁ is as defined above, in the presence of a tertiary amine in an organic solvent, for to give a sulfanylamide of formula (I) and / or a sulfinamidine compound of formula (II), in which R ₁ , R ₂ , R ₃ and R ₄ are as defined above; - optionally a 3 ^rd step, wherein the sulfinamidine compound of formula (II) or sulfanylamide mixture of formula (I) and of formula sulfinamidine (II) is converted in an organic solvent in the presence of an acid to give a compound sulfanylamide of formula (I), wherein R ₁ and R ₂ , R ₃ and R ₄ are as defined above. 2. Method according to claim 1, characterized in that the aryl group, when it is said to be substituted, is an aryl group substituted with one or more groups, which are identical or different from each other, chosen from the following atoms and groups: halogen, • optionally substituted alkyl, • alkoxy, • optionally substituted aryl, Optionally substituted heteroaryl, alkylene, • alkynyl, • fluoroalkyl, • fluoroalkoxy, Optionally substituted O-aryl, optionally substituted O-heteroaryl, • -S-alkyl, • -S-fluoroalkyl, Optionally substituted -S-aryl, Optionally substituted S-heteroaryl, -CN, • -NO ₂ , Heterocycloalkyl, • -N (Ra) (Rb), . -N (R ₃ ) CO (R _b ), -N (R ₃ ) COO (R _C ), • -N (R _c ) CON (R _a ) (R _b ), • -N (R ₃ ) SO ₂ (R _c ), • -OSO ₂ Rc, . -SO ₂ N (R ₃ ) (Rb), -SO ₂ (R _c ), . -CON (R ₃ ) (R _b ), • -COR _b and -COORc, wherein R ₃ and R _b are independently selected from hydrogen, optionally substituted (C ₁ -C ₄ ) alkyl, (C ₁ -C ₄ ) fluoroalkyl, cycloalkyl, optionally aryl substituted, optionally substituted heteroaryl, heterocycloalkyl and R _c takes the values of R ₃ except hydrogen, or R _a and R _b together with the nitrogen atom to which they are attached form a saturated or unsaturated heterocycle of 3 to 7 linkages, optionally comprising another heteroatom. 3. Process according to any one of Claims 1 to 2, characterized in that the heteroaryl group, when it is said to be substituted, is a heteroaryl group substituted with one or more groups, which are identical to or different from one another, chosen from among the atoms and groups: • halogen, • optionally substituted alkyl, • alkoxy, • optionally substituted aryl, Optionally substituted heteroaryl, • alkylene, • alkynyl, • fluoroalkyl, • fluoroalkoxy, Optionally substituted O-aryl, O-optionally substituted heteroaryl, -S-alkyl, • -S-fluoroalkyl, Optionally substituted -S-aryl, Optionally substituted S-heteroaryl, • -CN, • -NO ₂ , Heterocycloalkyl, . -N (Ra) CO (R _b ), -N (R ₃ ) COO (Rc), -N (R _c ) CON (R _a ) (R _b ), • -N (Ra) SO ₂ (R _c ), • -OSO ₂ Rc, • -SO ₂ N (R ₃ ) (R _b ), • -SO ₂ (Rc),. -CON (R ₃ ) (R _b ), • -COR _b and -COOR _c , wherein R ₃ , R _b and R _c are as defined in claim 2. 4. Process according to any one of Claims 1 to 3, characterized in that the alkyl group, when it is said to be substituted, is an alkyl group substituted with one or more groups, which are identical to or different from one another, chosen from the atoms and groups: • halogen, Optionally substituted aryl, optionally substituted heteroaryl, Heterocycloalkyl, • alkoxy, • fluoroalkyl, Optionally substituted fluoroalkoxy, -O-aryl, Optionally substituted O-heteroaryl, • -S-alkyl, • -S-fluoroalkyl, Optionally substituted -S-aryl; -S-heteroaryl optionally substituted, • -CN,. -NO ₂ , . -SO ₂ N (R ₃ ) (Rb), • -SO ₂ (Rc), -COR _b , • -COORc, • -CON (R ₃ ) (Rb), • -N (R ₃ ) (Rb), -N (R ₃ ) CO (Rb), -N (R ₃ ) COO (R _c ), • -N (R _c ) CON (R ₃ ) (R _b ), and. -N (R ₃ ) SO ₂ (Rc), wherein R ₃ , R _b and R ₀ are as defined in claim 2. 5. Process according to claim 1, characterized in that R 1 represents: a) an aryl optionally substituted with one or more groups (for example 1 to 3) groups, identical or different from each other, chosen from the following atoms and groups : • halogen, • optionally substituted alkyl, • alkoxy, • optionally substituted aryl, Optionally substituted heteroaryl, alkylene, • alkynyl, • fluoroalkyl, • fluoroalkoxy, • -S-fluoroalkyl, • -CN, • -NO ₂ , Heterocycloalkyl, • -N (R ₃ ) (R _b ), . -N (R _a ) CO (R _b ), -N (R _a ) COO (R _c ), • -OSO ₂ Rc, • -CON (R ₃ ) (R _b ), • -COR _b and -COORc, wherein R _a and R _b are independently selected from hydrogen, optionally substituted (C _r C ₄ ) alkyl, (C ₁ -C ₄ ) fluoroalkyl, cycloalkyl, optionally substituted aryl, optionally substituted heteroaryl , heterocycloalkyl and R _c takes the values of R ₃ except hydrogen, or R ₃ and R _b together with the nitrogen atom to which they are attached form a saturated or unsaturated 3 to 7-membered heterocycle optionally comprising another heteroatom; b) a heteroaryl optionally substituted with one or more groups (for example 1 to 3) groups, identical to or different from one another, chosen from the following atoms and groups: • halogen, • optionally substituted alkyl, • alkoxy, • fluoroalkyl, • fluoroalkoxy, • -CN, . -N (R _a ) (R ₆ ), • -COR _b and -COOR _c , wherein R _a , R _b and R _c are as defined above; c) an alkyl optionally substituted with one or more groups (for example 1 to 3) groups, identical or different from one another, chosen from the following atoms and groups: • halogen, Optionally substituted aryl, optionally substituted heteroaryl, Heterocycloalkyl, • alkoxy, • -S-alkyl, Fluoroalkyl, fluoroalkoxy, • -CN, • -NO ₂ • -COORc, . -CON (R ₃ ) (Rb), -N (R ₃ ) (R _b ), • -N (R ₃ ) CO (Rb), • -N (R ₃ ) COO (R _c ), • -N (R _c ) CON (R _a ) (R _b ), and -N (R _a ) SO ₂ (R ₀ ), wherein R ₃ , R _b and R _c are as defined above; d) an -SO ₂ -aryl group in which the aryl is optionally substituted by one or more (for example 1 to 3) groups, identical or different from one another, chosen from the following atoms and groups: • halogen, • alkyl, • alkoxy, • fluoroalkyl, • fluoroalkoxy, • -CN, • -NO ₂ , • -N (R ₃ ) (Rb), • -COR _b and • -COORc, where R ₃ , R _b and R _c are as defined previously; e) a -SO ₂ -heteroaryl group wherein the heteroaryl is optionally substituted by one or more (for example 1 to 3) groups, identical or different from each other, chosen from the following atoms and groups: • halogen, • alkyl, • alkoxy, • fluoroalkyl, • fluoroalkoxy, • -CN, • -N (Ra) (Rb), -COR _b and -COOR _c , where R _a , R _b and R ₀ are as defined above; f) a -SO ₂ -fluoroalkyl group; g) a -CO ₂ -alkyl group in which the alkyl is optionally substituted with one or more (for example 1 to 3) groups, which are identical to or different from each other, chosen from the following atoms and groups: • fluorine, • optionally substituted aryl, Optionally substituted heteroaryl, heterocycloalkyl, • alkoxy, • -S-alkyl, • fluoroalkyl, • fluoroalkoxy, • -CN, • -NO ₂ • -COORc, . -CON (Ra) (Rb), -N (Ra) (Rb), -N (R ₃ ) CO (R _b ), • -N (R ₃ ) COO (R _c ), • -N (R ₀ ) CON (Ra) (R _b ), and • -N (R ₃ ) SO ₂ (Rc), where R _a , R _b and R _c are as defined above. 6. Process according to any one of claims 1 to 5, characterized in that R ₂ represents a (CrC ₂ ) perfluoroalkyl group. 7. Process according to any one of claims 1 to 6, characterized in that R ₃ and R ₄ represent, independently of one another, an alkyl or alkoxyalkyl group or else R ₃ and R ₄ together with nitrogen atom to which they are attached, a morpholinyl group. 8. Process according to any one of claims 1 to 7, characterized in that R ₅ , R ₆ and R ₇ represent a methyl group. 9. Process according to any one of claims 1, 6, 7 or 8, characterized in that the compound of formula (III) is obtained by reaction of the compounds of formula (IV) and (V) at a temperature between - 40 ⁰ C and 40 ⁰ C. 10. Process according to claim 1, characterized in that the tertiary amine is chosen from triethylamine, N ₁ N diisopropylethylamine, pyridine or 2,6-lutidine. 11. The method of claim 1, characterized in that the organic solvent is a non-polar solvent which is preferably dichloromethane.